News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
617,928 Results
Type
Article (51068)
Company Profile (172)
Press Release (566688)
Section
Business (176789)
Career Advice (2660)
Deals (32055)
Drug Delivery (94)
Drug Development (76584)
Employer Resources (176)
FDA (16263)
Job Trends (13954)
News (310096)
Policy (31306)
Tag
Academia (2713)
Africa (850)
Alliances (47580)
Alzheimer's disease (1168)
Approvals (16188)
Arizona (123)
Artificial intelligence (77)
Asia (38735)
Australia (6418)
Bankruptcy (327)
Best Places to Work (10661)
Biosimilars (70)
Biotechnology (106)
C2C Services and Suppliers (64996)
California (1574)
Canada (831)
Cancer (407)
Career advice (2231)
Cell therapy (125)
China (133)
Clinical research (59673)
Collaboration (135)
Colorado (70)
Connecticut (61)
COVID-19 (2442)
Cystic fibrosis (74)
Data (218)
Diabetes (80)
Diagnostics (5653)
Drug pricing (71)
Earnings (63230)
Employer resources (152)
Europe (83897)
Events (83688)
Executive appointments (133)
FDA (16461)
Florida (234)
Funding (133)
Gene therapy (93)
GLP-1 (528)
Government (4166)
Healthcare (17164)
Hotbed/Location (409864)
Illinois (240)
Indiana (133)
Infectious disease (2471)
Inflammatory bowel disease (96)
Interviews (489)
IPO (14482)
Job creations (3379)
Job search strategy (1876)
Kansas (88)
Layoffs (360)
Legal (6731)
Liver cancer (57)
Lung cancer (102)
Manufacturing (86)
Maryland (371)
Massachusetts (1198)
Medical device (11609)
Medtech (11613)
Mergers & acquisitions (17424)
Metabolic disorders (248)
Michigan (119)
Minnesota (172)
Neuroscience (1310)
New Jersey (517)
New York (524)
NextGen Class of 2024 (6116)
Non-profit (4433)
North Carolina (557)
Northern California (718)
Obesity (152)
Ohio (100)
Opinion (205)
Patents (67)
Pennsylvania (478)
People (51796)
Phase I (18472)
Phase II (26253)
Phase III (19873)
Pipeline (103)
Policy (56)
Postmarket research (2256)
Preclinical (7951)
Press Release (72)
Rare diseases (129)
Real estate (5422)
Recruiting (69)
Regulatory (21327)
Research institute (2497)
Resumes & cover letters (433)
South America (1151)
Southern California (650)
Startups (3457)
Texas (212)
United States (7353)
Vaccines (472)
Washington State (224)
Weight loss (134)
Date
Today (127)
Last 7 days (577)
Last 30 days (2084)
Last 365 days (35428)
2024 (24243)
2023 (37726)
2022 (48125)
2021 (52352)
2020 (50740)
2019 (43894)
2018 (33320)
2017 (31091)
2016 (29896)
2015 (34478)
2014 (27035)
2013 (23089)
2012 (24726)
2011 (25496)
2010 (24216)
617,928 Results for "shanghai institutes for biological sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Outstanding Traditional Chinese Medicine Vitiligo Treatment Institution Establishes Itself in Shanghai, Aiming to Provide Specialized Treatment Solutions to More International Patients
Recently has unveiled a remarkable announcement: the inauguration of the Huahai Institute of Vitiligo Research in Shanghai.
September 26, 2023
·
5 min read
Policy
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical WorkflowsKR-HT5 is based on Akoya’s PhenoImager® HT Platform
Akoya Biosciences, Inc., The Spatial Biology Company®, and Shanghai KR Pharmtech have jointly announced that KR-HT5, which Akoya Biosciences co-developed with Shanghai KR Pharmtech utilizing the PhenoImager HT technology as its foundation, has received premarket approval from China’s National Medical Products Administration to support next generation pathology clinical workflows.
May 2, 2024
·
4 min read
Business
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
Dyadic International, Inc. announced it has advanced its collaboration with the Israel Institute for Biological Research (IIBR) and its commercial arm Life Science Research Israel.
February 21, 2024
·
5 min read
GenSci Launches Global Innovation Hub in Shanghai
Changchun GeneScience Pharmaceutical, a subsidiary of Changchun High-Tech Industries, held a groundbreaking ceremony for its new global headquarters and research & development center at Shanghai Zhangjiang International Medical Park on December 15th.
December 23, 2023
·
7 min read
BioForest
Allen Institute for Cell Science launches first disease-specific cell line collections
The Allen Institute for Cell Science unveiled a set of tools to accelerate research into hypertrophic cardiomyopathy, the most common genetic heart condition in the world: six new cell line collections, each carrying a different mutation associated with HCM.
June 4, 2024
·
5 min read
Bio NC
Carolina Partners with ChristianaCare Gene Editing Institute to Launch CRISPR in a Box™ Kits for High School Science Labs
Leading school science supplier Carolina Biological Supply Company announced an exclusive partnership with the ChristianaCare Gene Editing Institute to manufacture and distribute an affordable CRISPR in a Box™.
March 5, 2024
·
6 min read
BioMidwest
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
ADMA Biologics, Inc. announced Adam Grossman, President and Chief Executive Officer, will participate in a fireside chat at the Raymond James Institutional Investor Conference on March 6, 2024, at 11:35 a.m. ET.
March 5, 2024
·
2 min read
Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis
Shanghai Argo Biopharmaceutical Co., Ltd. announced that it has entered into two exclusive license and collaboration agreements with Novartis PHARMA AG.
January 7, 2024
·
3 min read
Deals
Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group
Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, announced it has completed the sale of a 20% equity stake in Shanghai RAAS to Haier Group Corporation and forged a strategic alliance with Haier Group.
June 18, 2024
·
7 min read
Press Releases
Boston Institute of Biotechnology & BiBo Pharma CEO Wins 2024 Global Biologics CDMO Technology Leadership Award
September 11, 2024
·
3 min read
1 of 61,793
Next